AIM ImmunoTech (AIM) Earnings Date, Estimates & Call Transcripts $0.26 0.00 (0.00%) (As of 10/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Earnings SummaryLatest Earnings DateAug. 14EstimatedActual EPS (Aug. 14) -$0.03 Missed By -$0.03 Get AIM ImmunoTech Earnings AlertsEnter your email address below to receive the latest news and earnings results for AIM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAIM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AIM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DarwinDon’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.Click here to get your FREE report delivered instantly! AIM ImmunoTech Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.35) EPSNext Year EPS Consensus Estimate: ($0.39) EPSAIM Earnings Date and InformationAIM ImmunoTech last issued its quarterly earnings data on August 14th, 2024. The reported ($0.03) earnings per share (EPS) for the quarter. The business earned $0.05 million during the quarter. AIM ImmunoTech has generated ($0.64) earnings per share over the last year (($0.64) diluted earnings per share). Earnings for AIM ImmunoTech are expected to decrease in the coming year, from ($0.35) to ($0.39) per share. Read More AIM ImmunoTech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/14/2024Q2 2024-($0.03)($0.03)($0.03)-$0.05 million5/16/2024Q1 2024-($0.12)($0.12)($0.12)-$0.04 million3/29/2024Q4 2023-($0.26)($0.26)($0.26)-$0.07 million11/15/2023Q3 2023($0.11)($0.16)($0.05)($0.16)-$0.05 million8/15/2023Q2 2023-($0.10)($0.10)($0.10)-$0.04 million5/12/2023Q1 2023-($0.08)($0.08)($0.08)-$0.05 million Get the Latest News and Ratings for AIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AIM ImmunoTech and its competitors with MarketBeat's FREE daily newsletter. 4/3/2023Q4 2022-($0.09)($0.09)($0.09)-$0.06 million11/15/2022Q3 2022-($0.13)($0.13)($0.13)-$0.02 million8/15/2022Q2 2022-($0.10)($0.10)($0.10)-$0.03 million5/16/2022Q1 2022-($0.08)($0.08)($0.08)-$0.03 million3/31/2022Q4 2021-($0.12)($0.12)($0.12)-$0.05 million11/16/2021Q3($0.0750)($0.08)($0.0050)($0.08)-$0.03 million8/15/2021Q2($0.0830)($0.12)($0.0370)($0.12)-$0.02 million5/18/2021Q1($0.0870)($0.08)+$0.0070($0.08)-$0.03 million3/30/2021Q4($0.0730)($0.09)($0.0170)($0.09)-$0.04 million11/19/2020Q3($0.0830)($0.08)+$0.0030($0.08)-$0.04 million8/14/2020Q2 2020-($0.11)($0.11)($0.11)-$0.04 million5/13/2020Q1 2020($0.0950)($0.22)($0.1250)($0.22)-$0.05 million11/14/2019Q3 2019-($1.13)($1.13)($1.13)-$0.06 million AIM ImmunoTech Earnings - Frequently Asked Questions When did AIM ImmunoTech announce their last quarterly earnings? AIM ImmunoTech (NYSE:AIM) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on AIM's earnings history. How much revenue does AIM ImmunoTech generate each year? AIM ImmunoTech (NYSE:AIM) has a recorded annual revenue of $201,000.00. How much profit does AIM ImmunoTech generate each year? AIM ImmunoTech (NYSE:AIM) has a recorded net income of -$28.96 million. AIM has generated -$0.64 earnings per share over the last four quarters. What is AIM ImmunoTech's EPS forecast for next year? AIM ImmunoTech's earnings are expected to decrease from ($0.35) per share to ($0.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies: KZR Earnings Results SYRS Earnings Results CDTX Earnings Results SNOA Earnings Results ANEB Earnings Results ATNM Earnings Results AFMD Earnings Results AADI Earnings Results BRNS Earnings Results VOR Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Goldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure Storage This page (NYSE:AIM) was last updated on 10/15/2024 by MarketBeat.com Staff From Our PartnersThe Masterworks of Cars - MCQ MarketsMCQ Markets is launching a new innovative platform that allows car enthusiasts to be able to invest in fractio...Issuance Express | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | SponsoredTop stock forecaster who predicted first Trump Stockwave makes new predictionWith some even predicting "A Trump win would tank the markets" But frequent Fox Business guest and Manward ...Manward Press | SponsoredAre you prepared for November 5November 5 is going to be a huge day for the crypto market … But it has nothing to do with the election. ...Weiss Ratings | SponsoredBreaking News: Elon Musk Unveils Groundbreaking New AI Type! Don't Miss It!This is Elon Musk's latest AI innovation… According to Eric Fry, a seasoned expert with 30 years of experie...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
